CEO Sam Tabar talked with Proactive about the company's major strategic shift in 2025 and its positioning at the ...
OKYO Pharma Ltd (NASDAQ:OKYO) earlier this week confirmed it is set to launch a Phase 2b/3 clinical trial for neuropathic corneal pain, following ...
CEO Alberto Rosende talked with Proactive about the company's mission to reshape the U.S. critical minerals supply chain. In ...
Virtuix Holdings Inc (NASDAQ:VTIX) earlier this week marked a significant milestone with its listing on the Nasdaq under the ticker symbol VTIX, as ...
CEO Brian Fowler joined Proactive to discuss discussed the recent approval of up to $4 million in funding from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results